LifePoint Health (LPNT) Tops Q2 EPS by 13c, Miss on Revenues; Offers Soft FY17 EPS/Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts LPNT Hot Sheet
Join SI Premium – FREE
LifePoint Health (NASDAQ: LPNT) reported Q2 EPS of $1.03, $0.13 better than the analyst estimate of $0.90. Revenue for the quarter came in at $1.59 billion versus the consensus estimate of $1.64 billion.
GUIDANCE:
LifePoint Health sees FY2017 EPS of $3.92-$4.20, versus the consensus of $4.19. LifePoint Health sees FY2017 revenue of $6.425-6.5 billion, versus the consensus of $6.55 billion.
For earnings history and earnings-related data on LifePoint Health (LPNT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Pfizer's 25-valent pneumococcal vaccine shows Phase 2 results
- Caldwell sells IQTalent subsidiary to WinMil for C$4.7M
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
